Not provided
Not provided
Not provided
Not provided
Not provided
no fund
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Hawaa Fertility Center | OTHER |
Not provided
Not provided
Not provided
Not provided
montelukast & dydrgesteron will be given to cases with suspected or proven ovarian hyperstimulation in one group in comparison with dydrogesteron alone in the other group.
patients with high risk for ovarian hyperstimulation will undergo a freeze-all protocol then montelukast & dydrgesteron will be given to cases with suspected or proven ovarian hyperstimulation in one group in comparison with dydrogesteron alone in the other group.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| control | Active Comparator | dydrgesterone 10 mg( tab)/12hs/14 days |
|
| study | Experimental | montelukast 10 mg(tab) oral/24hs/ 7 days dydrgesterone 10 mg( tab) oral/12hs/14 days |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| dydrgesterone 10 mg( tab)/12hs/14 days | Drug | Dydrogesterone Oral Tablet 10 mg twice daily for 14 days to be taken from the day of ovum pickup |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants who develop ovarian hyperstimulation syndrome | incidence | 0-14 days |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants treated of ovarian hyperstimulation syndrome | treatment & resolution | 0-14 days |
Not provided
Inclusion Criteria:
Exclusion Criteria:
infertile females undergoing ART cycles
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| ahmed sa saad, MD, ph D | Hawaa Fertility Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Banha University- Hawaa Fertility center | Banhā | Qalyubia Governorate | 13512 | Egypt |
study protocol, results,statistics
6 months
Not provided
Not provided
| ID | Term |
|---|---|
| D016471 | Ovarian Hyperstimulation Syndrome |
| ID | Term |
|---|---|
| D010049 | Ovarian Diseases |
| D000291 | Adnexal Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C093875 | montelukast |
| D013607 | Tablets |
| ID | Term |
|---|---|
| D004304 | Dosage Forms |
| D004364 | Pharmaceutical Preparations |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| montelukast 10 mg(tab) oral/24hs/ 7 days dydrgesterone 10 mg( tab) oral/12hs/14 days | Combination Product | montelukast 10 mg(tab) once daily oral for 7 days & dydrgesterone 10 mg (tab) twice daily oral for 14 days & |
|
| D005261 |
| Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D000091662 | Genital Diseases |
| D006058 | Gonadal Disorders |
| D004700 | Endocrine System Diseases |